Search for: "United States v. Bristol" Results 181 - 200 of 205
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Feb 2011, 9:44 pm by Kelly
‘obviousness-type’ double patenting practise (America-Israel Patent Law) Injunction by ORT Israel against World ORT using name in Israel overturned (The IP Factor) United Kingdom An epic tale of… erm, patents and trademarks – EWHC (Pat) decides Datacard v Eagle (IPKat) (EPLAW) EWHC (Ch): Play-Doah ruling goes Hasbro’s way: Hasbro v Nahrmittel (Class 46) (IPKat) Hargreaves and the SME litigants (Solo Independent IP Practitioners) The patent… [read post]
13 Nov 2022, 12:16 am by Frank Cranmer
Ilyin and Others v Ukraine (no. 74852/14): about the Kyiv City State Administration’s refusal to register a community of the Unification Church. [read post]
13 Dec 2009, 8:58 pm by smtaber
— Christopher Joyce, National Public Radio, December 7, 2009 The United States has all the tools it needs to replace its old coal energy economy and drastically cut greenhouse emissions. [read post]
27 Feb 2009, 7:00 am
(The IP Factor)   Uganda Anti-counterfeits conference held in Kampala (Afro-IP)   United Kingdom IP rights in the Court of Appeal, but not as we know them...: Office of Communications v Information Commissioner (IPKat) IPO review of practice before Patent Tribunal (PatLit) Employee inventor compensation: an expensive pastime? [read post]
18 Aug 2022, 12:26 pm by Josh Blackman
The majority opinion by Judge Jones followed precedent governing the Due Process Clause of the Fourteenth Amendment, and held that the foreign corporation was not "at home" in the United States. [read post]
25 Jul 2023, 1:43 am by Matthieu Dhenne (Dhenne Avocats)
The decision clarifies that a technical effect may be plausible without requiring the provision of tests or data; this is precisely the opposite of what was decided by Judge Arnold in the United Kingdom. [read post]
23 Aug 2008, 1:23 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: DRM for streaming music dies a quiet death: (Electronic Frontier Foundation), (Techdirt) CAFC decides Apotex and Impax infringed AstraZeneca’s Prilosec patents: (Law360), (Patent Prospector), (Patent Docs), (GenericsWeb), CAFC upholds lower court’s decision finding USPTO was within its rights to subject a Cooper patent to… [read post]
11 Apr 2008, 9:00 am
No problem…: Lundbeck A/S v Generics UK Ltd & Ors: (IPKat), Exelon (Rivastigmine Tartrate) – Dr Reddy’s and Novartis settle Exelon patent dispute: (Therapeutics Daily), GeneMaker – Codon Devices, Blue Heron Biotechnology settle patent suit over gene synthesis platform: (Patent Docs), Glucophage (Metformin) – Depomed settles patent litigation against IVAX: (SmartBrief), (IP Law360), (GenericsWeb), Lexapro… [read post]
16 May 2008, 8:03 am
: (GenericsWeb), Europe: New EBA referral T 1319/04 regarding patentability of known medicament for new treatment of same illness: (IPKat), Europe: Patentability of biotechnology in Europe: (IAM), Europe: New EPO Enlarged Board case referrals: T1319/04 Dosage Regimen, T1242/06 Essential Biological Process: (Hal Wegner), Thailand: Compulsory licensing: Affordable health for Thailand thanks to Matrix Labs: (Spicy IP), Thailand: European Parliament set to reprimand Mandelson for… [read post]
2 May 2008, 7:00 am
: Lupin v Abbott Labs: (FDA Law Blog), Plavix (Clopidogrel) – US: Apotex sues FDA to recover 180-day exclusivity on generic Plavix: (Orange Book Blog), Plavix (Clopidogrel) – US: Former Bristol-Myers Squibb executive charged over lying about Plavix deal struck with rival Apotex: (Managing Intellectual Property), Risperdal (Resperidone) – US: Apotex files motion to intervene in relisting of Risperdal patent case; Teva quickly files… [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
20 Jun 2008, 8:07 am
: (Spicy IP), Latin America: Merck Serono signs distribution agreement with Bristol-Myers Squibb for portfolio of established pharmaceutical brands in Latin America: (IP tango), US: Biotech industry growth to slow due to funding pressures and competition from biosimilars: (Managing Intellectual Property), US: House Commerce Committee posts responses to its questions on biogenerics; not surprisingly, the views run the gamut: (FDA Law Blog), US: Biosimilar debate heats up at BIO: (Managing… [read post]
15 Jul 2016, 7:18 pm
Affiliated with the American Economic Association and the Allied Social Sciences Association of the United States, ASCE maintains professional contacts with economists inside Cuba —whether independent or associated with the Cuban government— who are interested in engaging in scholarly discussion and research. [read post]
7 Jun 2010, 10:04 am by Steven M. Taber
In a recent enforcement action, EPA alleged that Michael Perugini violated the federal Lead Disclosure Rule when he failed to disclose information about lead paint to seven tenants when leasing units at his Bristol apartment buildings. [read post]
7 Jun 2010, 9:54 am by smtaber
In a recent enforcement action, EPA alleged that Michael Perugini violated the federal Lead Disclosure Rule when he failed to disclose information about lead paint to seven tenants when leasing units at his Bristol apartment buildings. [read post]
21 Dec 2009, 3:06 am
Miller (Lewis and Clark), Judith V. [read post]
14 Dec 2018, 7:16 pm
The internet platform then standing in the role of the state, but the state can go after the enterprise where it fails in its monitoring and controlling functions. [read post]
18 Apr 2012, 4:40 pm by Schachtman
Bristol-Meyers Squibb Co., 1998 WL 812318, at *23 (M.D. [read post]